Duke University clinical trials
Duke University is the lead sponsor of 10 current clinical trials in our Canada, Italy, Germany, Czechia, Japan, Australia, Mexico, Netherlands, France, Spain, Denmark, Switzerland, Austria, Israel, South Korea and Singapore registers. 7 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Tocilizumab, Abatacept and Amoxicillin. The most-studied condition is Polyarticular Course Juvenile Idiopathic Arthritis (JIA).
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Duke University
10 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
NCT04278404 · ClinicalTrials.gov ↗ · Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children
|
Observational | Recruiting | 2020-03 | Canada, Mexico |
|
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
NCT06399302 · ClinicalTrials.gov ↗ · Lung Transplant; Complications, Lung Transplant; Infection or Inflammation, Lung Transplant Rejection
|
Observational | Recruiting | 2024-09 | Canada |
|
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
NCT02418442 · ClinicalTrials.gov ↗ · Rheumatic Joint Disease
|
Observational | Recruiting | 2015-07 | Italy, Canada, Israel |
|
Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
NCT06816927 · ClinicalTrials.gov ↗ · Newly Diagnosed Glioblastoma
Drugs: Nivolumab, Relatlimab |
Phase 2 | Recruiting | 2025-11 | Australia |
|
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
NCT03511118 · ClinicalTrials.gov ↗ · Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI
|
Observational | Recruiting | 2018-10 | Canada, Mexico |
|
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
NCT06654882 · ClinicalTrials.gov ↗ · Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
|
Phase 3 | Recruiting | 2026-01 | Germany, Italy, Netherlands |
|
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
NCT06087029 · ClinicalTrials.gov ↗ · Type B Aortic Dissection
|
Not applicable | Recruiting | 2024-04 | Canada |
|
Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)
NCT02702869 · ClinicalTrials.gov ↗ · Cleft Lip, Cleft Palate, Cleft Lip and Palate
|
Observational | By invitation | 2016-10 | Canada |
|
5-SENSE Score Validation Study
NCT06138808 · Epilepsy Intractable
|
Observational | By invitation | 2024-01 | Germany, France, Spain, Denmark, Switzerland, Austria, Czechia, Canada, Japan, Australia |
|
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
NCT03681535 · ClinicalTrials.gov ↗ · Diffuse Large B Cell Lymphoma
|
Not applicable | Active, closed | 2019-02 | Italy, Czechia, Japan, South Korea, Singapore |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Duke University trials
41 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
+ 1 more in the trial list above.
Conditions in Duke University trials
19 conditionsBy trial register
A trial with sites in more than one country appears in each of those registers.
Questions about Duke University trials
How many clinical trials does Duke University sponsor?
Duke University is the lead sponsor of 10 current trials on ClinicalTrials.gov in our Canada, Italy, Germany, Czechia, Japan, Australia, Mexico, Netherlands, France, Spain, Denmark, Switzerland, Austria, Israel, South Korea and Singapore registers, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are Duke University trials recruiting?
Yes. 7 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Duke University testing?
Its current trials name 41 drugs and biologicals as interventions. The most frequent are Tocilizumab (2), Abatacept (1), Amoxicillin (1), Anakinra (1) and Azithromycin (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.